A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Nataly Tarasenko, Suzanne M. Cutts, Don R. Phillips, Gili Berkovitch-Luria, Elinor Bardugo-Nissim, Michal Weitman, Abraham Nudelman, Ada Rephaeli

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science